Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can High-Intensity workouts help stroke survivors regain muscle?

NCT ID NCT07456956

Recruiting now Symptom relief Sponsor: Fenerbahce University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether high-intensity interval training (HIIT) is better than moderate continuous exercise for treating muscle loss (sarcopenia) in people who have had an ischemic stroke. Researchers will measure changes in thigh muscle thickness, grip strength, walking ability, and quality of life in 32 participants over 6 weeks. The goal is to find the best exercise approach to improve recovery and daily function after a stroke.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MCIT) exercise programs
What this could lead to
If successful, this study could show that HIIT is a more effective exercise approach than moderate training for rebuilding muscle and improving mobility after a stroke.
What could go wrong
This is a small, early-stage trial with only 32 participants, so results may not apply to all stroke survivors. Exercise intensity may be hard for some to tolerate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SARCOPENIA STROKE ISCHEMIC

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fenerbahçe University

    RECRUITING

    Istanbul, Ataşehir, 34758, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.